NCT02982057View on ClinicalTrials.gov

Non Culprit Lesion Study

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 1, 2019

Study Completion Date

November 1, 2019

Conditions
STEMI
Interventions
DEVICE

the ABSORB:bioresorbable vascular scaffold

DRUG

O.M.T

Trial Locations (1)

1200

StLuc, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT02982057 - Non Culprit Lesion Study | Biotech Hunter | Biotech Hunter